QTWO
Price
$74.48
Change
+$3.25 (+4.56%)
Updated
Nov 4, 04:59 PM (EDT)
Capitalization
4.44B
105 days until earnings call
Intraday BUY SELL Signals
WEAV
Price
$7.40
Change
+$0.01 (+0.14%)
Updated
Oct 23 closing price
Capitalization
595.33M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QTWO vs WEAV

QTWO vs WEAV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
QTWO vs. WEAV commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTWO is a Buy and WEAV is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for QTWO with price predictions
Nov 03, 2026

Momentum Indicator for QTWO turns positive, indicating new upward trend

QTWO saw its Momentum Indicator move above the 0 level on October 05, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In 61 of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for QTWO just turned positive on October 05, 2026. Looking at past instances where QTWO's MACD turned positive, the stock continued to rise in 30 of 43 cases over the following month. The odds of a continued upward trend are 70%.

QTWO moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for QTWO crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.

Following a +6.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTWO advanced for three days, in 198 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 182 of 252 cases where QTWO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTWO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

QTWO broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. QTWO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.903) is normal, around the industry mean (-1.902). P/E Ratio (48.128) is within average values for comparable stocks, (15.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (4.643) is also within normal values, averaging (70.854).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTWO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for WEAV with price predictions
Nov 03, 2026

Aroon Indicator for WEAV shows an upward move is likely

WEAV's Aroon Indicator triggered a bullish signal on October 19, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 231 similar instances where the Aroon Indicator showed a similar pattern. In 185 of the 231 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 60 cases where WEAV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WEAV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.006) is normal, around the industry mean (4.691). WEAV has a moderately low P/E Ratio (-27.407) as compared to the industry average of (13.172). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (2.228) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. WEAV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
QTWO: Fundamental Ratings
QTWO
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QTWOWEAV
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend about 1 month ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (QTWO: $71.23 vs. WEAV: $7.40)
Brand notoriety: QTWO and WEAV are both not notable
QTWO represents the Packaged Software, while WEAV is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: QTWO: 94% vs. WEAV: 67%
Market capitalization -- QTWO: $4.44B vs. WEAV: $595.33M
QTWO [@Packaged Software] is valued at $4.44B. WEAV’s [@Services to the Health Industry] market capitalization is $595.33M. The market cap for tickers in the [@Packaged Software] industry ranges from $39 to $265.82B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.09B. The average market capitalization across the [@Packaged Software] industry is $10.44B. The average market capitalization across the [@Services to the Health Industry] industry is $3.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTWO’s FA Score shows that 0 FA rating(s) are green while WEAV’s FA Score has 1 green FA rating(s).

  • QTWO’s FA Score: 0 green, 5 red.
  • WEAV’s FA Score: 1 green, 4 red.
According to our system of comparison, WEAV is a better buy in the long-term than QTWO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTWO’s TA Score shows that 6 TA indicator(s) are bullish while WEAV’s TA Score has 1 bullish TA indicator(s).

  • QTWO’s TA Score: 6 bullish, 4 bearish.
  • WEAV’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, QTWO is a better buy in the short-term than WEAV.

Price Growth

QTWO (@Packaged Software) experienced а +4.55% price change this week, while WEAV (@Services to the Health Industry) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Packaged Software industry was -0.63%. For the same industry, the average monthly price growth was -2.50%, and the average quarterly price growth was -0.43%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.18%. For the same industry, the average monthly price growth was -0.16%, and the average quarterly price growth was +14.22%.

Reported Earning Dates

QTWO is expected to report earnings on Feb 17, 2027.

WEAV is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Packaged Software (-0.63% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

@Services to the Health Industry (+1.18% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

QTWO and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTWO has been closely correlated with PCOR. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if QTWO jumps, then PCOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTWO
1D Price
Change %
QTWO100%
+1.12%
PCOR - QTWO
71%
Closely correlated
+0.96%
WK - QTWO
70%
Closely correlated
-1.05%
NCNO - QTWO
65%
Loosely correlated
-2.33%
WDAY - QTWO
64%
Loosely correlated
-0.10%
BL - QTWO
63%
Loosely correlated
-2.20%
More

WEAV and

Correlation & Price change

A.I.dvisor indicates that over the last year, WEAV has been loosely correlated with QTWO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if WEAV jumps, then QTWO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WEAV
1D Price
Change %
WEAV100%
N/A
QTWO - WEAV
61%
Loosely correlated
+1.12%
DOCN - WEAV
58%
Loosely correlated
+0.79%
NOW - WEAV
55%
Loosely correlated
+2.97%
DBX - WEAV
55%
Loosely correlated
-1.91%
HUBS - WEAV
54%
Loosely correlated
-3.14%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIR25.001.74
+7.48%
Madison Air Solutions Corp
BOBS17.04-0.37
-2.13%
Bob's Discount Furniture Inc.
CHGG0.65-0.02
-2.64%
CHEGG
ISPC0.79-0.04
-5.12%
iSpecimen Inc.
GYRE4.44-0.29
-6.13%
Gyre Therapeutics